1h Free Analyst Time
The onychomycosis treatment market is forecasted to grow by USD 1.77 billion during 2023-2028, accelerating at a CAGR of 7.03% during the forecast period. The report on the onychomycosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of onychomycosis, increasing awareness of onychomycosis treatment, and growing aging population.
The onychomycosis treatment market is segmented as below:
By Type
- Pharmacological
- Non-pharmacological
By Distribution Channel
- Offline
- Online
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the onychomycosis treatment market covers the following areas:
- Onychomycosis treatment market sizing
- Onychomycosis treatment market forecast
- Onychomycosis treatment market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global onychomycosis treatment market: Alembic Pharmaceuticals Ltd., Almirall SA, Astellas Pharma Inc., Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr Reddys Laboratories Ltd., Fotona d.o.o, Galderma SA, GlaxoSmithKline Plc, Kaken Pharmaceutical Co. Ltd., Lupin Ltd., Medimetriks Pharmaceuticals Inc., Moberg Pharma AB, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and The OTClab B.V..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing demand for topical treatment for onychomycosis."
According to the report, one of the major drivers for this market is the increasing prevalence of onychomycosis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alembic Pharmaceuticals Ltd.
- Almirall SA
- Astellas Pharma Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Cipla Inc.
- Dr Reddys Laboratories Ltd.
- Fotona d.o.o
- Galderma SA
- GlaxoSmithKline Plc
- Kaken Pharmaceutical Co. Ltd.
- Lupin Ltd.
- Medimetriks Pharmaceuticals Inc.
- Moberg Pharma AB
- Novartis AG
- Perrigo Co. Plc
- Pfizer Inc.
- Sanofi SA
- Teva Pharmaceutical Industries Ltd.
- The OTClab B.V.
